Epredia, a global leader in precision cancer diagnostics, Sep. 5 announced that its parent company PHC Holdings Corporation acquired anatomical pathology suppliers Microm Microtech France (MMFrance) and Laurypath in a strategic expansion of Epredia’s presence in Europe

You need to subscribe for access to restricted content.

Subscribe